Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150.

Anika MangWei ZouVinzent RolnyMartin ReckDaniel CigoianuKatja SchulzeStefan HoldenriederMark A SocinskiDavid S ShamesBirgit WehnlNamrata S Patil

Published in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (2023)

gov: NCT02366143.

Keyphrases